Peter Bloch

Guarden Capital, Inc. operates as a boutique advisory firm that provide strategic and managerial assistance to small and medium sized enterprises. It offers financial capital, CFO support and assistance with strategic direction. The company is headquartered in Toronto, Canada.

Tribute Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, licensing and management of pharmaceuticals products in Canada. Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that treat recognized medical conditions and diseases. Their goal is to provide quality products that improve patient outcomes. Tribute is seeking to expand its product portfolio in Canada through strategic partnerships with other pharmaceutical, biotechnology and specialty pharmaceutical companies interested in gaining market experience in Canada.

Part of Bionik Laboratories Corp., Bionik Laboratories, Inc. develops healthcare solutions for patients with restricted physical mobility. The company is based in Toronto, Canada. Bionik Laboratories was acquired by Bionik Laboratories Corp. on February 27, 2015. Peter David Bloch has been the CEO of the Canadian company since 2011.

Bionik Mergerco, Inc. develops and supplies medical devices and robotics technologies. The company is headquartered in Toronto, Canada.

Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada.

EnerSpar Corp. is an exploration company. It engages in the acquisition, exploration, development, and production of industrial mineral resources. The firm holds interest in the Johan Beetz Feldspar property. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.